| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
Insider buying and selling activity across 88 companies in the Health Care Providers & Services industry. Part of the Health Care sector.
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | 3M | 12M | SEC |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Mar 4, 2024 | OSCR Oscar Health, Inc. | Blackley Richard Scott56 | Chief Financial Officer | Sell | 14,346 | $15.88 | $227,814.48 | -2.4% | +25.1% | +0.4% | |
| Mar 4, 2024 | HSIC Henry Schein Inc | Breslawski James P65 | Vice Chairman, President | Sell | 2,907 | $76.50 | $222,385.50 | -1.3% | -9.3% | -8.4% | |
| Mar 4, 2024 | CI Cigna Group | Cordani David67 | Chairman &CEO | Sell | 19,288 | $332.62 | $6,415,574.56 | -5.4% | +1.4% | -8.3% | |
| Mar 4, 2024 | MCK McKesson Corp | Rutledge Napoleon B Jr | SVP, Controller &CAO | Sell | 190 | $529.99 | $100,698.12 | -17.6% | +7.3% | +20.5% | |
| Mar 4, 2024 | OSCR Oscar Health, Inc. | Quane Alessandrea C.51 | EVP, Chief Insurance Officer | Sell | 15,928 | $15.88 | $252,936.64 | -7.6% | +25.1% | +0.4% | |
| Mar 4, 2024 | OSCR Oscar Health, Inc. | Baltrus Victoria47 | Chief Accounting Officer | Sell | 33,707 | $15.88 | $535,267.16 | -22.2% | +25.1% | +0.4% | |
| Mar 4, 2024 | CI Cigna Group | Jones Nicole S54 | See Remarks | Sell | 4,436 | $332.62 | $1,475,502.32 | -12.3% | +1.4% | -8.3% | |
| Mar 4, 2024 | CI Cigna Group | Triplett Michael W51 | Special Advisor | Sell | 1,953 | $332.62 | $649,606.86 | -5.7% | +1.4% | -8.3% | |
| Mar 1, 2024 | UHS Universal Health Services Inc | Sussman Elliot J Md Mba59 | Director | Sell | 3,492 | $170.99 | $597,104.06 | -46.9% | +8.6% | +2.4% | |
| Mar 1, 2024 | THC Tenet Healthcare Corp | Arnst Thomas W | EVP, Chief Admin. Officer &GC | Sell | 17,000 | $94.84 | $1,612,233.80 | -29.5% | +41.2% | +34.3% | |
| Mar 1, 2024 | HSIC Henry Schein Inc | Kuehn Kurt P56 | Director | Sell | 1,582 | $77.07 | $121,924.74 | -10.4% | -9.9% | -6.1% | |
| Mar 1, 2024 | EHAB Enhabit, Inc. | Langham Ronald Leroy Jr | EVP Clinical Excel. &Strategy | Sell | 634 | $8.81 | $5,585.54 | -1.1% | +4.4% | -5.0% | |
| Mar 1, 2024 | PGNY Progyny, Inc. | Livingston Mark S.83 | Chief Financial Officer | Sell | 12,610 | $36.64 | $461,976.92 | -6.5% | -26.1% | -37.5% | |
| Mar 1, 2024 | PGNY Progyny, Inc. | Sturmer Michael E80 | President | Sell | 11,009 | $36.63 | $403,259.67 | -7.2% | -26.1% | -37.5% | |
| Mar 1, 2024 | LFST Lifestance Health Group, Inc. | Mullins Kevin Michael57 | Chief Development Officer | Sell | 115,136 | $8.02 | $923,390.72 | -2.5% | -28.5% | +0.1% | |
| Feb 29, 2024 | AMN Amn Healthcare Services Inc | Foletta Mark G72 | Director | Buy | 500 | $56.90 | $28,450.00 | +6.2% | -4.0% | -55.0% | |
| Feb 29, 2024 | AMN Amn Healthcare Services Inc | Harris R Jeffrey | Director | Buy | 2,640 | $56.97 | $150,400.80 | +5.1% | -4.0% | -55.0% | |
| Feb 29, 2024 | DGX Quest Diagnostics Inc | Doherty Catherine T.55 | EVP, Regional Businesses | Sell | 6,744 | $126.45 | $852,769.05 | -4.7% | +10.6% | +38.4% | |
| Feb 29, 2024 | DGX Quest Diagnostics Inc | Prevoznik Michael E52 | SVP &General Counsel | Sell | 5,611 | $125.88 | $706,312.68 | -12.7% | +10.6% | +38.4% | |
| Feb 28, 2024 | AMN Amn Healthcare Services Inc | Knudson Jeffrey R | CFO | Buy | 6,951 | $57.75 | $401,420.25 | +33.3% | -1.1% | -52.4% | |
| Feb 28, 2024 | AMN Amn Healthcare Services Inc | Wheat Douglas D59 | Director | Buy | 2,620 | $56.87 | $148,999.40 | +172.0% | -1.1% | -52.4% | |
| Feb 28, 2024 | AMN Amn Healthcare Services Inc | Trent-Adams Sylvia | Director | Buy | 175 | $57.02 | $9,978.50 | +4.9% | -1.1% | -52.4% | |
| Feb 28, 2024 | AMN Amn Healthcare Services Inc | Laughlin Whitney M | Chief Legal Officer | Buy | 863 | $57.74 | $49,829.62 | +6.3% | -1.1% | -52.4% | |
| Feb 28, 2024 | HCSG Healthcare Services Group Inc | Brophy Andrew M | Principal Accounting Officer | Sell | 1,125 | $12.58 | $14,152.50 | -12.7% | -15.4% | -16.9% | |
| Feb 28, 2024 | OPCH Option Care Health, Inc. | Bavaro Michael52 | Chief Human Resources Officer | Sell | 1,984 | $31.73 | $62,944.19 | -4.4% | -5.9% | +5.0% |
The blue line has two modes, toggled with the Relative and Absolute buttons:
Relative (default) shows cumulative industry performance with both the overall market and parent sector movements removed. When the line rises above 100, the industry is outperforming its sector; below 100 means underperforming. This is calculated using factor returns via weighted least squares (WLS) regression, isolating pure industry-specific behavior.
Absolute shows the total cumulative return of the industry including market and sector movement. This reflects what an investor actually experienced — an industry can show strong absolute gains even while underperforming its sector in relative terms.
Both views start at an index of 100. Other return drivers such as momentum, value, or size are deliberately retained in both modes, since these are part of what makes an industry behave the way it does and may reflect the conditions insiders are responding to.